Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zengshun Kou

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Cancer Medicine|March 10, 2025
PRR11 Promotes Bladder Cancer Growth and Metastasis by Facilitating G1/S Progression and Epithelial-Mesenchymal TransitionLu Wang, Zengshun Kou, Jiaxi Zhu, et al.
International Journal of General Medicine|March 4, 2024
Exploring the Molecular Mechanisms and Shared Gene Signatures Between Systemic Lupus Erythematosus and Bladder Urothelial CarcinomaKongjia Wang, Shufei Wang, Yixin Ding, et al.
Discover Oncology|April 5, 2025
Multi-omics analysis identifies DLX4 as a novel biomarker for diagnosis, prognosis, and immune infiltration: from pan-cancer to renal cancerZengshun Kou, Shuaizhi Zhu, Jiaxi Zhu, et al.
Journal of Cellular and Molecular Medicine|March 18, 2024
CPA4 as a biomarker promotes the proliferation, migration and metastasis of clear cell renal cell carcinoma cellsKongjia Wang, Yixin Ding, Yunbo Liu, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Cancer Medicine|March 10, 2025
PRR11 Promotes Bladder Cancer Growth and Metastasis by Facilitating G1/S Progression and Epithelial-Mesenchymal TransitionLu Wang, Zengshun Kou, Jiaxi Zhu, et al.
International Journal of General Medicine|March 4, 2024
Exploring the Molecular Mechanisms and Shared Gene Signatures Between Systemic Lupus Erythematosus and Bladder Urothelial CarcinomaKongjia Wang, Shufei Wang, Yixin Ding, et al.
Discover Oncology|April 5, 2025
Multi-omics analysis identifies DLX4 as a novel biomarker for diagnosis, prognosis, and immune infiltration: from pan-cancer to renal cancerZengshun Kou, Shuaizhi Zhu, Jiaxi Zhu, et al.
Journal of Cellular and Molecular Medicine|March 18, 2024
CPA4 as a biomarker promotes the proliferation, migration and metastasis of clear cell renal cell carcinoma cellsKongjia Wang, Yixin Ding, Yunbo Liu, et al.
Pageof 1